Skip to main content
OpenTrials

Clinical trial condition

Intrahepatic Cholangiocarcinoma

Explore clinical trials studying Intrahepatic Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

72 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Intrahepatic Cholangiocarcinoma trial results

Completed

Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

NCT01862315

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Completed

REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

NCT04526106

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 48 locations
View Trial Details
Completed

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma

NCT05678218

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +15 more
Locations
  • University Hospital of Ghent Ghent, Belgium
  • Maastricht UMC+ Maastricht, Limburg, Netherlands
  • Amsterdam University Medical Center Amsterdam, North Holland, Netherlands
  • University Medical Center Groningen Groningen, Provincie Groningen, Netherlands
View Trial Details

Related conditions